Objective
The overall objective is to establish in a prospective, randomized, placebo controlled trial whether daily oral administration of high dose nicotinamide can produce a clinically useful reduction in the rate of progression to IDDM in relatives at increased risk of contracting the disease. Specific aims are:
1.To complete recruitment to the expanded ENDIT trial and perform the 3 year interim statistical review.
2.To extend and strengthen the current multinational programme of screening for risk of IDDM in first degree relatives.
3.To develop and test new strategies for risk assessment within this population, including application of novel miniaturized high-throughput genetic and immune assay systems.
4. To establish an international collaborative network capable of undertaking a programme of prompt, high quality and cost-effective intervention trials in individuals at high risk of progression to IDDM.
Nicotinamide, a soluble B group vitamin, has been known for many years to offer protection to pancreatic beta cells against a variety of toxic agents both in vivo and in vitro. Recent research has established a sound scientific rationale for its use in attempted prevention of human type 1 diabetes, and promising pilot studies have been performed. ENDIT, a five year trial of sustained release nicotinamide versus placebo as a potential means of delaying the onset of type 1 diabetes, is the first multinational diabetes prevention trial to get under way. Non-diabetic high risk first degree relatives have been randomized to treatment in 11 European countries, Canada and the USA, while 11 additional European countries are currently preparing to participate. A total of 201 local centres are involved. The aim over the past 3 years has been to set up the trial and to randomize 320 patients to treatment by the end of 1995; we are on course for this target. The inclusion of additional national groups now enables us to extend recruitment to the trial in order to improve its statistical power. We have therefore increased the target for recruitment to 530 high risk relatives, on the assumption that a minimum of 422 will complete the trial. This will give us 90% power to detect a 40% treatment effect, as against 50% effect with the previous design. Screening and recruitment of the additional numbers needed will be completed by 1997, and the three year interim statistical review, timed from recruitment of the first 211 patients, will be carried out in summer 1998. Further, the network that has been established is now in a position to develop a long term programme of diabetes prevention trials. In preparation for this we are networking the 15 laboratories involved in screening for risk of diabetes more closely, and will extend our training programme. In addition we aim to develop and test novel high throughput screening methods for immune and genetic markers, in concert with the PARADIGM centralized facility, in order to improve the precision and efficiency of risk estimation.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.